The link between reduced AKT activity and increased BIM expression levels is FOXO3A, a member of the forkhead family of transcriptional regulators that can directly increase BIM expression levels and induce apoptosis in cancer cells when overexpressed [19], [29], [30]. The gene discussed is BCL2L11; the disease is cancer.